Zoetis Inc. (ZTS)

166.44 +2.29 (+1.40%) At close: 04:05PM EDT

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 13,800

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Kristin C. Peck	CEO & Director	3.86M	7.64M	1971
Mr. Wetteny N. Joseph	Exec. VP & CFO	2.91M	N/A	1972
Ms. Heidi C. Chen	Exec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics	1.39M	5.56M	1967
Ms. Roxanne Lagano	Exec. VP and Chief HR Officer & Global Operations	N/A	N/A	1965
Ms. Wafaa Mamilli	EVP, Chief Digital & Tech. Officer, Group Pres for China, Brazil and Preci. Animal Health	N/A	N/A	1968
Mr. Steven Frank	VP of Investor Relations	N/A	N/A	N/A
Mr. William Price	VP & Chief Communications Officer	N/A	N/A	N/A
Dr. Robert J. Polzer Ph.D.	Exec. VP and Pres of R&D	N/A	N/A	1969
Ms. Jeannette Ferran Astorga	Exec. VP of Corp. Affairs & Communications and Chief Sustainability Officer	N/A	N/A	1975
Mr. Nick Ashton	Exec. VP and Pres of Global Manufacturing & Supply	N/A	N/A	1973

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides testing and analysis of blood, urine, and other animal samples and related products and services, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate Governance

Zoetis Inc.’s ISS Governance QualityScore as of March 30, 2023 is 3. The pillar scores are Audit: 5; Board: 1; Shareholder Rights: 7; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.